title: Incidence of cytomegalovirus infection in kidney recipients.
authors.affiliation: Başkent University School of Medicine, Department of General Surgery, Ankara, Turkey.
authors.forename: N
authors.initials: N
authors.lastname: Bilgin
authors.forename: H
authors.initials: H
authors.lastname: Karakayali
authors.forename: G
authors.initials: G
authors.lastname: Moray
authors.forename: H
authors.initials: H
authors.lastname: Akkoç
authors.forename: M
authors.initials: M
authors.lastname: Turan
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D002102:Cadaver; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology*; D005190:Family; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006085:Graft Survival; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000401:mortality; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D012189:Retrospective Studies; D016019:Survival Analysis; D014019:Tissue Donors; D014421:Turkey / Q000453:epidemiology
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3